SG1906 for CLDN18.2-Positive Solid Tumors

Clinical trial NCT05857332 · RECRUITING

Trial details

NCT number: NCT05857332
Sponsor: Hangzhou Sumgen Biotech Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Unresectable or Metastatic Solid Tumors

Start date: 2023-05-30
Primary completion: 2027-02-28
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.